| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 59 |
| 1 | CAPECITABINE | 58 |
| 2 | ADALIMUMAB | 53 |
| 3 | FLUOROURACIL | 43 |
| 4 | FLUOROURACIL CREAM, 0.5% | 43 |
| 5 | OXALIPLATIN | 40 |
| 6 | INFLIXIMAB | 29 |
| 7 | CISPLATIN | 25 |
| 8 | PREDNISONE | 24 |
| 9 | VEDOLIZUMAB | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLURBIPROFEN SODIUM | 1 | 0.0179 |
| 1 | DIMETICONE | 1 | 0.0035 |
| 2 | FLURBIPROFEN | 5 | 0.0033 |
| 3 | TOLCAPONE | 1 | 0.0028 |
| 4 | VARDENAFIL | 1 | 0.0017 |
| 5 | ZIV-AFLIBERCEPT | 2 | 0.0015 |
| 6 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 1 | 0.0014 |
| 7 | RAMUCIRUMAB | 8 | 0.0013 |
| 8 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| 9 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 8 | 0.0013 |
| 1 | Methylating Agent [EPC] | 1 | 0.0010 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 63 | 0.0003 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 88 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 9 | Integrin Receptor Antagonist [EPC] | 24 | 0.0003 |